A Targeted Approach to HealthCare
Bayer HealthCare Pharmaceuticals' goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, we focus our efforts where we can have the most impact.
For more than 100 years, Bayer has been dedicated to developing, manufacturing and marketing pharmaceuticals. Built on the company's long history of providing medicines that healthcare providers and patients can trust, Bayer is one of the most recognized brands in health care.
Bayer News Releases
10 April 2012
Bayer Updates Labels for Drospirenone-containing
Combination Oral Contraceptives
14 March 2012
U.S. FDA APPROVES FIRST AND ONLY ORAL CONTRACEPTIVE DEMONSTRATED TO TREAT HEAVY MENSTRUAL BLEEDING(HMB)
29 February 2012
U.S. FDA APPROVES LOWER DOSE FORMULATION OF ANGELIQ® (DROSPIRENONE AND ESTRADIOL) TABLETS
2 February 2012
BAYER EXPANDS ITS HEMOPHILIA LEADERSHIP DEVELOPMENT PROGRAM Company Seeking Applicants for Prestigious Summer Internship
2 February 2012
Bayer Initiates Expanded Access Program for Investigational Compound Radium-223 Chloride
17 January 2012
Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI), LBA #385:
more
10 January 2012 - Bayer News Releases....... Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI): more
8 December 2011 - Bayer News Releases....... Bayer's drospirenone-containing combination oral contraceptives more
11 November 2011 - Bayer News Releases....... BAYER VIRTUAL WALK FOR HEMOPHILIA RAISES AWARENESS AND FUNDS FOR PEOPLE WITH BLEEDING DISORDERS more
26 October 2011 - Bayer News Releases....... Phase III Trial of Bayer’s Investigational Compound Regorafenib (BAY 73-4506) in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival more
12 October 2011 - Bayer News Releases....... Bayer HealthCare and Onyx Pharmaceuticals Restructure Global Oncology Partnership ... more
23 September 2011 - Bayer News Releases....... Results of Phase III Study in Patients with Castration-Resistant Prostate Cancer and Symptomatic Bone Metastases more
13 September 2011 - Bayer News Releases....... Bayer to Present New Data Evaluating Investigational Oncology Compounds at 2011 ECCO-ESMO Congress more
6 June 2011 - Bayer News Releases....... Bayer’s Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone more
18 May 2011 - Bayer News Releases....... Nexavar Data To Be Presented at American Society of Clinical Oncology Annual Meeting more
18 May 2011 - Bayer News Releases....... Bayer to Present Data on Investigational Oncology Compounds at 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) more
10 May 2011 - Bayer News Releases....... FDA Grants Fast Track Designation to Bayer’s Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors more
25 April 2011 - Bayer News Releases....... KOGENATE® FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FOR HEMOPHILIA A NOW EASIER FOR PEOPLE TO STORE AT HOME OR ON THE GO more
21 April 2011 - Bayer News Releases....... BAYER AFFIRMS BENEFIT-RISK PROFILE OF ITS ORAL CONTRACEPTIVES more
14 April 2011 - Bayer News Releases....... BAYER LAUNCHES FIRST INTERACTIVE VIRTUAL WALK IN SUPPORT OF HEMOPHILIA more
04 April 2011 - Bayer News Releases....... April 4, 2011 - BAYER HEALTHCARE SELECTS THE STATE OF NEW JERSEY FOR EAST COAST SITE CONSOLIDATION more
25 March 2011 - Bayer News Releases....... NEW INTERIM DATA ABOUT COMBINATION ORAL CONTRACEPTIVES more
15 March 2011 - Bayer News Releases....... TV PERSONALITY VANESSA MINNILLO TEAMS UP WITH BAYER AND MARCH OF DIMES TO LAUNCH NATIONAL FOLATE AWARENESS CAMPAIGN more
14 March 2011 - Bayer News Releases....... U.S. FDA Approves Bayer’s Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System more
4 February 2011 - Bayer News Releases....... FDA Grants Orphan Drug Designation to Bayer’s Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors more
10 January 2011 - Bayer News Releases....... Bayer HealthCare Marks Opening of U.S. Innovation Center more
08 January 2011 - Bayer News Releases....... Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group’s Alcohol Prep Products more
16 December 2010 - Bayer News Releases....... U.S. FDA APPROVES SECOND BAYER ORAL CONTRACEPTIVE THAT ALSO RAISES FOLATE LEVELS more
24 September 2010 - Bayer News Releases....... Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), BeyazTM more
28 June 2010 - Bayer News Releases....... Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing their Treatment more
17 June 2010 - Bayer News Releases....... Teva Admits to Making False Statements in US Gianvi™ Label and Agrees to Corrective Measures more
15 June 2010 - Bayer News Releases....... Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva’s Generic Oral Contraceptive GianviTM more
14 June 2010 - Bayer News Releases....... Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival more
17 May 2010 - Bayer News Releases....... Bayer HealthCare Enhances U.S. Research Strategy with New Innovation Center more
6 May 2010 - Bayer News Releases....... U.S. FDA APPROVES NATAZIATM, A NEW ORAL CONTRACEPTIVE FOR THE PREVENTION OF PREGNANCY more
17 April 2010 - Bayer News Releases....... Bayer HealthCare Marks 2010 World Hemophilia Day with a $350,000 Contribution to the World Federation of Hemophilia more
9 April 2010 - Bayer News Releases....... BAYER UPDATES LABELS FOR YAZ and YASMIN Body of Evidence Affirms VTE Risk/Benefit Profile for YAZ and Yasmin Is Comparable to Other Combination Oral Contraceptives more
11 March 2010 - Bayer News Releases....... FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis more